FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4206349005> ?p ?o ?g. }

• W4206349005 endingPage "109811" @default.
• W4206349005 startingPage "109811" @default.
• W4206349005 abstract "Pancreatic cancer will be the second leading cause of cancer-related mortality worldwide due to its high rate of metastasis. Cathepsins (CATs) are effectors of invasive growth in various cancers. Currently, targeting CATs represents an attractive strategy for the treatment of highly metastatic cancers with high CATs activity, such as pancreatic cancer. To develop a stronger antimetastatic agent, ASPER-29, a novel inhibitor of CATs designed by using the asperphenamate derivative BBP as a lead compound, was synthesized, and its therapeutic potential in pancreatic cancer metastasis was investigated in this study. Molecular docking and enzyme inhibition assays proved that ASPER-29 can inhibit the activity of CAT-L and CAT-S by binding with these enzymes in classical action modes. Furthermore, ASPER-29 significantly inhibited the activity of CAT-L and CAT-S but had no effect on their expression in PANC-1 and BxPC-3 cells. The in vitro antimetastatic activities of ASPER-29 were examined by wound healing and Transwell chamber assays. We found that ASPER-29 inhibited the migration and invasion of PANC-1 and BxPC-3 cells in a concentration-dependent manner. Moreover, the in vivo antimetastatic effects of ASPER-29 were confirmed in a mouse xenotransplantation model. H&E staining and immunohistochemistry assays of Ki67 and CEACAM6 proved that ASPER-29 treatment significantly blocked the metastasis of pancreatic cancer cells to lung and liver tissues. Additionally, the activity of both CAT-L and CAT-S was markedly inhibited in the lung and liver tissues of ASPER-29-administered mice compared with the mice in the model group, suggesting that the metastasis-blocking effect of ASPER-29 should be mediated via inhibition of the activity of CAT-L and CAT-S in pancreatic cancer cells. Together, our results demonstrated that ASPER-29, as a novel inhibitor of CAT-L and CAT-S, possessed the evident ability to block the metastasis of pancreatic cancer cells." @default.
• W4206349005 created "2022-01-25" @default.
• W4206349005 creator A5024901495 @default.
• W4206349005 creator A5039863028 @default.
• W4206349005 creator A5046214153 @default.
• W4206349005 creator A5049332951 @default.
• W4206349005 creator A5066321574 @default.
• W4206349005 creator A5079125461 @default.
• W4206349005 creator A5081720398 @default.
• W4206349005 creator A5087411164 @default.
• W4206349005 date "2022-02-01" @default.
• W4206349005 modified "2023-09-29" @default.
• W4206349005 title "ASPER-29 suppresses the metastasis of pancreatic cancer cells by dual inhibition of cathepsin-L and cathepsin-S" @default.
• W4206349005 cites W1197219833 @default.
• W4206349005 cites W1757407923 @default.
• W4206349005 cites W1823586356 @default.
• W4206349005 cites W1968812902 @default.
• W4206349005 cites W1975749473 @default.
• W4206349005 cites W1993672505 @default.
• W4206349005 cites W2000614562 @default.
• W4206349005 cites W2019552640 @default.
• W4206349005 cites W2022716479 @default.
• W4206349005 cites W2041617023 @default.
• W4206349005 cites W2042406691 @default.
• W4206349005 cites W2052603632 @default.
• W4206349005 cites W2061345986 @default.
• W4206349005 cites W2070460611 @default.
• W4206349005 cites W2086160302 @default.
• W4206349005 cites W2088978926 @default.
• W4206349005 cites W2095457805 @default.
• W4206349005 cites W2097619603 @default.
• W4206349005 cites W2103233599 @default.
• W4206349005 cites W2110063674 @default.
• W4206349005 cites W2110171529 @default.
• W4206349005 cites W2123377725 @default.
• W4206349005 cites W2125823333 @default.
• W4206349005 cites W2128307445 @default.
• W4206349005 cites W2129636440 @default.
• W4206349005 cites W2134740745 @default.
• W4206349005 cites W2147640616 @default.
• W4206349005 cites W2155593291 @default.
• W4206349005 cites W2172208023 @default.
• W4206349005 cites W2176714462 @default.
• W4206349005 cites W2336731262 @default.
• W4206349005 cites W2397703541 @default.
• W4206349005 cites W2491220498 @default.
• W4206349005 cites W2552678153 @default.
• W4206349005 cites W2594538327 @default.
• W4206349005 cites W2772417595 @default.
• W4206349005 cites W2799466853 @default.
• W4206349005 cites W2892208366 @default.
• W4206349005 cites W2916664436 @default.
• W4206349005 cites W2921846932 @default.
• W4206349005 cites W2923584057 @default.
• W4206349005 cites W2955220852 @default.
• W4206349005 cites W3008740081 @default.
• W4206349005 cites W3029198228 @default.
• W4206349005 cites W3195053803 @default.
• W4206349005 cites W4244640572 @default.
• W4206349005 cites W2901485926 @default.
• W4206349005 doi "https://doi.org/10.1016/j.cbi.2022.109811" @default.
• W4206349005 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35016848" @default.
• W4206349005 hasPublicationYear "2022" @default.
• W4206349005 type Work @default.
• W4206349005 citedByCount "2" @default.
• W4206349005 countsByYear W42063490052022 @default.
• W4206349005 countsByYear W42063490052023 @default.
• W4206349005 crossrefType "journal-article" @default.
• W4206349005 hasAuthorship W4206349005A5024901495 @default.
• W4206349005 hasAuthorship W4206349005A5039863028 @default.
• W4206349005 hasAuthorship W4206349005A5046214153 @default.
• W4206349005 hasAuthorship W4206349005A5049332951 @default.
• W4206349005 hasAuthorship W4206349005A5066321574 @default.
• W4206349005 hasAuthorship W4206349005A5079125461 @default.
• W4206349005 hasAuthorship W4206349005A5081720398 @default.
• W4206349005 hasAuthorship W4206349005A5087411164 @default.
• W4206349005 hasConcept C109523444 @default.
• W4206349005 hasConcept C121608353 @default.
• W4206349005 hasConcept C126322002 @default.
• W4206349005 hasConcept C142724271 @default.
• W4206349005 hasConcept C150903083 @default.
• W4206349005 hasConcept C167844969 @default.
• W4206349005 hasConcept C181199279 @default.
• W4206349005 hasConcept C204232928 @default.
• W4206349005 hasConcept C207001950 @default.
• W4206349005 hasConcept C2778442404 @default.
• W4206349005 hasConcept C2779013556 @default.
• W4206349005 hasConcept C2779904517 @default.
• W4206349005 hasConcept C2780034444 @default.
• W4206349005 hasConcept C2780210213 @default.
• W4206349005 hasConcept C28021979 @default.
• W4206349005 hasConcept C2911091166 @default.
• W4206349005 hasConcept C502942594 @default.
• W4206349005 hasConcept C55493867 @default.
• W4206349005 hasConcept C71924100 @default.
• W4206349005 hasConcept C86803240 @default.
• W4206349005 hasConceptScore W4206349005C109523444 @default.
• W4206349005 hasConceptScore W4206349005C121608353 @default.

• next